Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03689972
Brief Title: A Study to Evaluate Efficacy, Safety, and Tolerability of EID of Natalizumab (BG00002) in Participants With RRMS Switching From Treatment With Natalizumab SID in Relation to Continued SID Treatment- Followed by Extension Study Comprising SC and IV Natalizumab Administration

First Submitted : September 27, 2018
First Submitted that Met QC Criteria : September 27, 2018
First Posted : October 1, 2018

Last Update Submitted that Met QC Criteria : September 17, 2020
Last Update Posted : September 18, 2020